Cell Therapy

Companies: 2,731
Sector: Healthcare
Overview

Cell Therapy is a key segment within the Healthcare sector, comprising 2,731+ companies actively operating in this space.

This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.

Browse the comprehensive directory of Cell Therapy companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.

Top Companies in Cell Therapy

Discover leading companies in this segment, ranked by company performance and market presence.

Juno Therapeutics
junotherapeutics.com

CAR T-cell and T-cell receptor immunotherapies for cancer are developed.

Founded 2013
Location Seattle, Washington, United States
Employees 520 As on 31 Dec 2017
Total Funding USD 316.67 M As on 05 Oct 2017

CAR-T and TIL immunotherapies for solid tumors are developed.

Founded 2018
Location San Francisco, California, United States
Revenue USD 61 K As on 31 Dec 2024
Employees 300 As on 31 Dec 2024
Total Funding USD 493 M As on 25 Jul 2025
Immatics
immatics.com

T-cell-based immunotherapies for cancer treatment are developed.

Founded 2000
Location Tubingen, Baden-wurttemberg, Germany
Revenue USD 168.57 M As on 31 Dec 2024
Net Profit USD 16.46 M As on 31 Dec 2024
Employees 423 As on 31 Dec 2024
Total Funding USD 236.4 M As on 24 Jul 2023
Autolus
autolus.com

Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases.

Founded 2015
Location London, England, United Kingdom
Revenue USD 10.12 M As on 31 Dec 2024
Employees 647 As on 31 Dec 2024
Total Funding USD 181.37 M As on 08 Feb 2024
NuVasive
nuvasive.com

Smart surgical devices for spinal surgery are developed.

Founded 1997
Location San Diego, California, United States
Total Funding USD 54.1 M As on 26 May 2020

Genetically engineered cell therapies are developed for multiple disorders.

Founded 2018
Location Seattle, Washington, United States
Employees 194 As on 31 Dec 2024
Total Funding USD 821 M As on 25 Jun 2020

Provider of bio-artificial pancreas for Type 1 Diabetes treatment

Founded 2015
Location Cambridge, Massachusetts, United States
Employees 58 As on 31 Dec 2022
Total Funding USD 158 M As on 26 Feb 2019
GigaGen
gigagen.com

T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.

Founded 2011
Location San Francisco, California, United States
Employees 36 As on 31 Dec 2022
Total Funding USD 36.13 M As on 16 Jan 2018
ArsenalBio
arsenalbio.com

Developer of immune cell therapies

Founded 2019
Location San Francisco, California, United States
Employees 178 As on 31 Dec 2022
Total Funding USD 631.16 M As on 09 Jul 2024
Cue Biopharma
cuebiopharma.com

Cue Biopharma is focused on developing immunotherapy solutions.

Founded 2015
Location Cambridge, Massachusetts, United States
Revenue USD 9.29 M As on 31 Dec 2024
Employees 41 As on 31 Dec 2024
Total Funding USD 10 M As on 21 Nov 2022
Cabaletta Bio
cabalettabio.com

Developer of CAAR T cells for B cell-mediated autoimmune diseases

Founded 2017
Location Radnor, Pennsylvania, United States
Employees 161 As on 31 Dec 2024
Total Funding USD 88.26 M As on 03 Jan 2019

Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies

Founded 2015
Location San Diego, California, United States
Revenue USD 64.7 M As on 31 Dec 2023
Employees 259 As on 31 Dec 2022
Total Funding USD 323.78 M As on 07 Aug 2023

Stem cell therapies are developed for cardiovascular and neurological diseases.

Founded 2016
Location Boston, Massachusetts, United States
Employees 138 As on 31 Dec 2022
Total Funding USD 225 M As on 12 Dec 2016

T-cell therapies for cancer treatment are developed by Bolt Biotherapeutics.

Founded 2015
Location Redwood City, California, United States
Revenue USD 7.69 M As on 31 Dec 2024
Employees 52 As on 31 Dec 2024
Total Funding USD 177.49 M As on 07 Jun 2021

Cell-based therapeutics for cancer treatment are developed.

Founded 2021
Location San Mateo, California, United States
Employees 42 As on 31 Dec 2022
Total Funding USD 200 M As on 09 Feb 2023
Tenaya Therapeutics
tenayatherapeutics.com

Regenerative and gene therapeutics for heart failure are developed.

Founded 2016
Location San Francisco, California, United States
Employees 97 As on 31 Dec 2024
Total Funding USD 142 M As on 03 Feb 2025

Chimeric antigen receptor macrophages are developed for cancer treatment.

Founded 2016
Location Philadelphia, Pennsylvania, United States
Revenue USD 19.63 M As on 31 Dec 2024
Employees 46 As on 31 Dec 2024
Total Funding USD 3.85 M As on 22 Sep 2022
Athira Pharma
athira.com

Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed.

Founded 2011
Location Seattle, Washington, United States
Employees 26 As on 31 Dec 2024
Total Funding USD 121.04 M As on 08 Dec 2020

T-cell therapies for cancer treatment are developed.

Founded 2007
Location San Carlos, California, United States
Revenue USD 164.07 M As on 31 Dec 2024
Employees 838 As on 31 Dec 2024
Orca Bio
orcabio.com

Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders

Founded 2016
Location Menlo Park, California, United States
Employees 66 As on 31 Dec 2021
Total Funding USD 442 M As on 09 Jan 2026

Explore Companies in Cell Therapy

Access detailed company profiles, financial data, funding information, and more for all companies in this segment.

View All Companies